Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
AYURCANN HOLDINGS CORP. ANNOUNCES BUYBACK OF COMMON SHARES UNDER NORMAL COURSE ISSUER BID
-
Proactive news headlines including Suvo Strategic Minerals, Lake Resources, Queensland Pacific Metals and KGL Resources
-
Proactive news headlines including Suvo Strategic Minerals, Lake Resources, Queensland Pacific Metals and KGL Resources
-
Liquid Meta Announces Participation in Upcoming Investor Events
-
Zedcor Inc. Announces Proposed Public Offering of Units and Conversion of Series 1 Preferred Shares
-
Sustainable Real Estate Dividend Fund Files Final Prospectus
-
PharmaCann and LivWell Enlightened Health Announce Completion of Merger
-
Form 8.3 - [Clinigen Group plc - 25 02 2022] - (CGWL)
-
Biogen (BIIB) PT Lowered to $285 at Canaccord Genuity
-
Form 8.3 - [Clinigen Group plc - 24 02 2022] - (CGWL)
-
Source Rock Royalties Files Final Prospectus for Upsized Initial Public Offering
-
NanoXplore Inc. Announces Closing of $30 Million Bought Deal Public Offering
-
Canaccord Genuity Upgrades Definitive Healthcare Corp (DH) to Buy
-
Baroyeca Gold & Silver Inc. Announces Private Placement Financing Closed and Investor Relations Contract
-
SoftBank-backed Gousto in $230 million secondary placing
-
Calyxt Announces Closing of SEC-Registered Offering of Common Stock, Pre-Funded Warrants to Purchase Common Stock and Warrants to Purchase Common Stock
-
Mogo to Participate in the Canaccord Genuity Digital Disruptor Conference
-
Nevada Vanadium Engages Canaccord and Announces Private Placement for Gross Proceeds of up to $4,000,000
-
Panbela Therapeutics Inc. (PBLA) Acquires Cancer Prevention Pharmaceuticals
-
Panbela Therapeutics Inc. (PBLA) to Acquire Cancer Prevention Pharmaceuticals
-
Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.
-
Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.
-
DraftKings Inc. (DKNG) PT Lowered to $55 at Canaccord Genuity
-
Amryt Completes $125 Million Non-Dilutive Debt Refinancing
-
Amryt Completes $125 Million Non-Dilutive Debt Refinancing
-
Elemental Royalties Announces 53% Increase in Revenue for Q4 2021
-
Atalaya Mining PLC Announces Director/PDMR Shareholding
-
Spectrum Brands Completes Acquisition of Tristar Products’ Kitchen Appliances and Cookware Business
-
Conformis, Inc. to Participate in Upcoming Investor Conferences
-
Cronos Group (CRON:CN) (CRON) PT Lowered to Cdn$4.25 at Canaccord Genuity
-
Tenth Avenue Petroleum Corp. Announces Closing of $3,138,750 Non-Brokered Financing
-
Calyxt (CLXT) Prices $10.4M Share and Warrant Private Placement at $1.41/sh
-
Postmedia to Acquire Brunswick News Inc. and Extend Maturity of its First and Second Lien Notes
-
Calxyt, Inc. Announces Pricing of $10.9 Million SEC-Registered Offering of Common Stock and Warrants
-
Ninepoint Partners Announces First Closing of Ninepoint 2022 Flow-Through Limited Partnership
-
CMP 2022 Resource Limited Partnership Raises $13,585,000 on First Closing
-
Canaccord Genuity Downgrades Coeur d'Alene Mines (CDE) to Hold
-
MRF 2022 Resource Limited Partnership: Second Closing March 24, 2022
-
AMEX Closes C$49.6 Million Bought Deal Private Placement
-
WonderFi Announces Buyback of up to 7,935,883 Shares
-
Form 8.3 - [Clinigen Group plc - 16 02 2022] - (CGWL)
-
Movable Ink To Acquire Coherent Path
-
Artemis Announces Promotion of Olly Forrer to Principal
-
Salona Global Medical Device Corporation Announces the Closing of $4.26 Million Bought Deal Private Placement
-
NanoXplore Inc. Announces $30 Million “Bought Deal” Public Offering
-
UPDATE: Canaccord Genuity Starts Lantronix, Inc. (LTRX) at Buy
-
WonderFi Announces 2022 Q1 Financial Results
-
Form 8.3 - [Clinigen Group plc - 10 02 2022] - (CGWL)
-
CoTec Holdings Corp. Announces Initial Closing of Subscription Receipt Financing
-
Proactive news headlines including Empower Clinics, Kovo HealthTech, Thunderbird Entertainment, Cypress Development and Gungnir

